Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

23LW

Crystal structure of SARS-CoV-2 main protease A173V mutant in complex with leritrelvir

Summary for 23LW
Entry DOI10.2210/pdb23lw/pdb
Descriptor3C-like proteinase nsp5, Leritrelvir bound form (3 entities in total)
Functional Keywordssars-cov-2, nsp5, main protease, coronavirus, protease inhibitor, alpha-ketoamide inhibitor, peptidomimetic inhibitor, viral protein
Biological sourceSevere acute respiratory syndrome coronavirus 2
Total number of polymer chains2
Total formula weight68990.64
Authors
Huang, X.,Li, Q.,Yang, Z.,Zhong, N.,Xiong, X. (deposition date: 2026-02-11, release date: 2026-06-03)
Primary citationHuang, X.,Kuzmic, P.,Zhang, S.,Chen, X.,Gui, J.,Li, Q.,Zou, B.,Yan, S.,Song, L.,Niu, C.,Zhao, Y.,Lin, H.,Wang, N.,Chen, J.,Chen, X.,Chen, J.,Zhong, N.,Yang, Z.,Xiong, X.
Superior Target Binding by Leritrelvir Induces Dimerization of Mpro Mutants and Mitigates Drug Resistance
To Be Published,
Experimental method
X-RAY DIFFRACTION (1.65 Å)
Structure validation

254917

PDB entries from 2026-06-10

PDB statisticsPDBj update infoContact PDBjnumon